Summary
Amendment to the Health Insurance (Diagnostic Imaging Services Table) Regulations governing Medicare benefits for diagnostic imaging services including X-rays, CT scans, MRI, ultrasound, and other imaging modalities. The instrument establishes rebate amounts, claiming conditions, and service eligibility criteria for approximately 500+ diagnostic imaging items under the Medicare Benefits Schedule (MBS).
Reason
While price controls and subsidies distort the diagnostic imaging market and impose compliance burdens on providers, deletion of this instrument would remove Medicare rebates for diagnostic imaging services that approximately 80% of Australians rely upon. Without subsidised access to diagnostic imaging, many Australians—particularly low-income households—would face prohibitive out-of-pocket costs for essential diagnostic procedures (e.g., $300-500+ for MRI). This would likely reduce preventive diagnostic uptake, delay detection of serious conditions (cancers, fractures, internal injuries), and disproportionately harm vulnerable populations. The unintended consequence of deletion would be worse health outcomes for Australians who cannot afford unsubsidised imaging, ultimately increasing downstream healthcare costs through delayed treatment. The regulatory framework, while imperfect, provides a mechanism for maintaining baseline diagnostic access that cannot be easily replicated through private markets alone given information asymmetries and essential nature of these services.